Dual bronchodilator therapy for chronic obstructive pulmonary disease
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pulmonary and Respiratory Medicine
Reference59 articles.
1. How do dual long-acting bronchodilators prevent exacerbations of chronic obstructive pulmonary disease?;Beeh;Am J Respir Crit Care Med,2017
2. The scientific rationale for combining long-acting B2-agonists and muscarinic antagonists in COPD;Cazzola;Pulm Pharmacol Ther,2010
3. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease (TORCH);Calverley;N Engl J Med,2007
4. Long-term safety and efficacy of indacaterol, a long-acting B2-agonist, in subjects with COPD: a randomized, placebo-controlled study;Chapman;Chest,2011
5. Lung function efficacy and symptomatic benefit from olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies;Koch;Int J Chron Obstruct Pulmon Dis,2014
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Overuse of long-acting β 2 -agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns;Postgraduate Medicine;2023-11-17
2. Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting β2-Agonists in Patients With COPD;Chest;2023-04
3. The double bronchodilation era: new capabilities in a new drug delivery device;Meditsinskiy sovet = Medical Council;2022-04-06
4. Assessment of physical functioning in patients with chronic obstructive pulmonary disease (COPD) requiring long-acting dual bronchodilation in routine clinical practice;Medicina de Familia. SEMERGEN;2021-07
5. Regional Gas Exchange Measured by 129 Xe Magnetic Resonance Imaging Before and After Combination Bronchodilators Treatment in Chronic Obstructive Pulmonary Disease;Journal of Magnetic Resonance Imaging;2021-05-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3